{
  "DOI": "10.1038/ejhg.2016.94",
  "ISSN": [
    "1018-4813",
    "1476-5438"
  ],
  "URL": "http://dx.doi.org/10.1038/ejhg.2016.94",
  "alternative-id": [
    "BFejhg201694"
  ],
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 1,
      "value": "12 August 2016"
    },
    {
      "group": {
        "label": "Competing interests",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1,
      "value": "AW has received payments for speaker services from AstraZeneca and payments for consultancy from AstraZeneca and Roche Products."
    }
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Wallace",
      "given": "Andrew J",
      "sequence": "first"
    }
  ],
  "container-title": [
    "European Journal of Human Genetics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2016,
        8,
        12
      ]
    ],
    "date-time": "2016-08-12T08:50:59Z",
    "timestamp": 1470991859000
  },
  "deposited": {
    "date-parts": [
      [
        2023,
        5,
        18
      ]
    ],
    "date-time": "2023-05-18T17:17:57Z",
    "timestamp": 1684430277000
  },
  "indexed": {
    "date-parts": [
      [
        2024,
        4,
        25
      ]
    ],
    "date-time": "2024-04-25T12:33:28Z",
    "timestamp": 1714048408107
  },
  "is-referenced-by-count": 72,
  "issn-type": [
    {
      "type": "print",
      "value": "1018-4813"
    },
    {
      "type": "electronic",
      "value": "1476-5438"
    }
  ],
  "issue": "S1",
  "issued": {
    "date-parts": [
      [
        2016,
        8,
        12
      ]
    ]
  },
  "journal-issue": {
    "issue": "S1",
    "published-print": {
      "date-parts": [
        [
          2016,
          9
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "https://creativecommons.org/licenses/by-nc-sa/4.0",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2016,
            8,
            12
          ]
        ],
        "date-time": "2016-08-12T00:00:00Z",
        "timestamp": 1470960000000
      }
    }
  ],
  "link": [
    {
      "URL": "http://www.nature.com/articles/ejhg201694.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://www.nature.com/articles/ejhg201694",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://www.nature.com/articles/ejhg201694.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "S10-S18",
  "prefix": "10.1038",
  "published": {
    "date-parts": [
      [
        2016,
        8,
        12
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2016,
        8,
        12
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2016,
        9
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1200/JCO.2006.09.1066",
      "author": "S Chen",
      "doi-asserted-by": "publisher",
      "first-page": "1329",
      "journal-title": "J Clin Oncol",
      "key": "BFejhg201694_CR1",
      "unstructured": "Chen S, Parmigiani G : Meta-analysis of BRCA1 and BRCA2 penetrance. J Clin Oncol 2007; 25: 1329–1333.",
      "volume": "25",
      "year": "2007"
    },
    {
      "DOI": "10.1093/jnci/djt095",
      "author": "N Mavaddat",
      "doi-asserted-by": "publisher",
      "first-page": "812",
      "journal-title": "J Natl Cancer Inst",
      "key": "BFejhg201694_CR2",
      "unstructured": "Mavaddat N, Peock S, Frost D et al: Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE. J Natl Cancer Inst 2013; 105: 812–822.",
      "volume": "105",
      "year": "2013"
    },
    {
      "DOI": "10.1186/s13058-014-0442-6",
      "author": "DG Evans",
      "doi-asserted-by": "publisher",
      "first-page": "442",
      "journal-title": "Breast Cancer Res",
      "key": "BFejhg201694_CR3",
      "unstructured": "Evans DG, Barwell J, Eccles DM et al: The Angelina Jolie effect: how high celebrity profile can have a major impact on provision of cancer related services. Breast Cancer Res 2014; 16: 442.",
      "volume": "16",
      "year": "2014"
    },
    {
      "author": "J Kluger",
      "first-page": "28",
      "journal-title": "TIME Magazine",
      "key": "BFejhg201694_CR4",
      "unstructured": "Kluger J, Park A : The Angelina Effect. TIME Magazine 2013; 181: 28–33.",
      "volume": "181",
      "year": "2013"
    },
    {
      "DOI": "10.6004/jnccn.2014.0127",
      "author": "NCCN Clinical Practice Guidelines",
      "doi-asserted-by": "publisher",
      "first-page": "1326",
      "journal-title": "J Natl Compr Canc Netw",
      "key": "BFejhg201694_CR5",
      "unstructured": "NCCN Clinical Practice Guidelines: Genetic/familial high-risk assessment: breast and ovarian, version 1.2014. J Natl Compr Canc Netw 2014; 12: 1326–1338.",
      "volume": "12",
      "year": "2014"
    },
    {
      "DOI": "10.1093/annonc/mdr373",
      "author": "J Balmana",
      "doi-asserted-by": "crossref",
      "first-page": "vi31",
      "issue": "Suppl 6",
      "journal-title": "Ann Oncol",
      "key": "BFejhg201694_CR6",
      "unstructured": "Balmana J, Diez O, Rubio IT, Cardoso F. : BRCA in breast cancer: ESMO Clinical Practice Guidelines. Ann Oncol 2011; 22 (Suppl 6): vi31–vi34.",
      "volume": "22",
      "year": "2011"
    },
    {
      "DOI": "10.1002/ijc.22817",
      "author": "MJ Bermejo-Perez",
      "doi-asserted-by": "publisher",
      "first-page": "225",
      "journal-title": "Int J Cancer",
      "key": "BFejhg201694_CR7",
      "unstructured": "Bermejo-Perez MJ, Marquez-Calderon S, Llanos-Mendez A : Effectiveness of preventive interventions in BRCA1/2 gene mutation carriers: a systematic review. Int J Cancer 2007; 121: 225–231.",
      "volume": "121",
      "year": "2007"
    },
    {
      "key": "BFejhg201694_CR8",
      "unstructured": "NICE Clinical Guidelines: NICE Clinical Guidance 164: Familial Breast Cancer. NICE Clinical Guidelines 2013, Available at www.nice.org.uk/Guidance/CG164 ."
    },
    {
      "DOI": "10.1056/NEJM199705153362001",
      "author": "JP Struewing",
      "doi-asserted-by": "publisher",
      "first-page": "1401",
      "journal-title": "N Engl J Med",
      "key": "BFejhg201694_CR9",
      "unstructured": "Struewing JP, Hartge P, Wacholder S et al: The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med 1997; 336: 1401–1408.",
      "volume": "336",
      "year": "1997"
    },
    {
      "DOI": "10.1038/nm1196-1179",
      "author": "P Tonin",
      "doi-asserted-by": "publisher",
      "first-page": "1179",
      "journal-title": "Nat Med",
      "key": "BFejhg201694_CR10",
      "unstructured": "Tonin P, Weber B, Offit K et al: Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer families. Nat Med 1996; 2: 1179–1183.",
      "volume": "2",
      "year": "1996"
    },
    {
      "DOI": "10.1002/ijc.20162",
      "author": "B Gorski",
      "doi-asserted-by": "publisher",
      "first-page": "683",
      "journal-title": "Int J Cancer",
      "key": "BFejhg201694_CR11",
      "unstructured": "Gorski B, Jakubowska A, Huzarski T et al: A high proportion of founder BRCA1 mutations in Polish breast cancer families. Int J Cancer 2004; 110: 683–686.",
      "volume": "110",
      "year": "2004"
    },
    {
      "DOI": "10.1111/cge.12360",
      "author": "M Szwiec",
      "doi-asserted-by": "publisher",
      "first-page": "288",
      "journal-title": "Clin Genet",
      "key": "BFejhg201694_CR12",
      "unstructured": "Szwiec M, Jakubowska A, Górski B et al: Recurrent mutations of BRCA1 and BRCA2 in Poland: an update. Clin Genet 2015; 87: 288–292.",
      "volume": "87",
      "year": "2015"
    },
    {
      "DOI": "10.1101/gr.6.11.1029",
      "author": "TM Smith",
      "doi-asserted-by": "publisher",
      "first-page": "1029",
      "journal-title": "Genome Res",
      "key": "BFejhg201694_CR13",
      "unstructured": "Smith TM, Lee MK, Szabo CI et al: Complete genomic sequence and analysis of 117 kb of human DNA containing the gene BRCA1. Genome Res 1996; 6: 1029–1049.",
      "volume": "6",
      "year": "1996"
    },
    {
      "DOI": "10.1007/s10549-012-2009-5",
      "author": "E Rouleau",
      "doi-asserted-by": "publisher",
      "first-page": "1179",
      "journal-title": "Breast Cancer Res Treat",
      "key": "BFejhg201694_CR14",
      "unstructured": "Rouleau E, Jesson B, Briaux A et al: Rare germline large rearrangements in the BRCA1/2 genes and eight candidate genes in 472 patients with breast cancer predisposition. Breast Cancer Res Treat 2012; 133: 1179–1190.",
      "volume": "133",
      "year": "2012"
    },
    {
      "DOI": "10.1371/journal.pone.0093306",
      "author": "L Fachal",
      "doi-asserted-by": "publisher",
      "first-page": "e93306",
      "journal-title": "PLoS One",
      "key": "BFejhg201694_CR15",
      "unstructured": "Fachal L, Blanco A, Santamarina M, Carracedo A, Vega A : Large genomic rearrangements of BRCA1 and BRCA2 among patients referred for genetic analysis in Galicia (NW Spain): delimitation and mechanism of three novel BRCA1 rearrangements. PLoS One 2014; 9: e93306.",
      "volume": "9",
      "year": "2014"
    },
    {
      "DOI": "10.1111/j.1399-0004.2007.00773.x",
      "author": "YK Lim",
      "doi-asserted-by": "publisher",
      "first-page": "331",
      "journal-title": "Clin Genet",
      "key": "BFejhg201694_CR16",
      "unstructured": "Lim YK, Lau PT, Ali AB et al: Identification of novel BRCA large genomic rearrangements in Singapore Asian breast and ovarian patients with cancer. Clin Genet 2007; 71: 331–342.",
      "volume": "71",
      "year": "2007"
    },
    {
      "DOI": "10.1016/j.canep.2010.04.010",
      "author": "NA Sharifah",
      "doi-asserted-by": "publisher",
      "first-page": "442",
      "journal-title": "Cancer Epidemiol",
      "key": "BFejhg201694_CR17",
      "unstructured": "Sharifah NA, Nurismah MI, Lee HC et al: Identification of novel large genomic rearrangements at the BRCA1 locus in Malaysian women with breast cancer. Cancer Epidemiol 2010; 34: 442–447.",
      "volume": "34",
      "year": "2010"
    },
    {
      "DOI": "10.1007/s10549-010-1018-5",
      "author": "P Kang",
      "doi-asserted-by": "publisher",
      "first-page": "579",
      "journal-title": "Breast Cancer Res Treat",
      "key": "BFejhg201694_CR18",
      "unstructured": "Kang P, Mariapun S, Phuah SY et al: Large BRCA1 and BRCA2 genomic rearrangements in Malaysian high risk breast-ovarian cancer families. Breast Cancer Res Treat 2010; 124: 579–584.",
      "volume": "124",
      "year": "2010"
    },
    {
      "DOI": "10.1007/s11033-013-2775-0",
      "author": "H Rudnicka",
      "doi-asserted-by": "publisher",
      "first-page": "6619",
      "journal-title": "Mol Biol Rep",
      "key": "BFejhg201694_CR19",
      "unstructured": "Rudnicka H, Debniak T, Cybulski C et al: Large BRCA1 and BRCA2 genomic rearrangements in Polish high-risk breast and ovarian cancer families. Mol Biol Rep 2013; 40: 6619–6623.",
      "volume": "40",
      "year": "2013"
    },
    {
      "DOI": "10.1007/s00432-005-0678-8",
      "author": "A Pietschmann",
      "doi-asserted-by": "publisher",
      "first-page": "552",
      "journal-title": "J Cancer Res Clin Oncol",
      "key": "BFejhg201694_CR20",
      "unstructured": "Pietschmann A, Mehdipour P, Mehdipour P et al: Mutation analysis of BRCA1 and BRCA2 genes in Iranian high risk breast cancer families. J Cancer Res Clin Oncol 2005; 131: 552–558.",
      "volume": "131",
      "year": "2005"
    },
    {
      "DOI": "10.1089/gte.2006.10.104",
      "author": "AM Moisan",
      "doi-asserted-by": "publisher",
      "first-page": "104",
      "journal-title": "Genet Test",
      "key": "BFejhg201694_CR21",
      "unstructured": "Moisan AM, Fortin J, Dumont M et al: No evidence of BRCA1/2 genomic rearrangements in high-risk French-Canadian breast/ovarian cancer families. Genet Test 2006; 10: 104–115.",
      "volume": "10",
      "year": "2006"
    },
    {
      "DOI": "10.1086/302974",
      "author": "The BRCA1 Exon 13 Duplication Screening Group",
      "doi-asserted-by": "publisher",
      "first-page": "207",
      "journal-title": "Am J Hum Genet",
      "key": "BFejhg201694_CR22",
      "unstructured": "The BRCA1 Exon 13 Duplication Screening Group: The exon 13 duplication in the BRCA1 gene is a founder mutation present in geographically diverse populations. Am J Hum Genet 2000; 67: 207–212.",
      "volume": "67",
      "year": "2000"
    },
    {
      "author": "FB Hogervorst",
      "first-page": "1449",
      "journal-title": "Cancer Res",
      "key": "BFejhg201694_CR23",
      "unstructured": "Hogervorst FB, Nederlof PM, Gille JJ et al: Large genomic deletions and duplications in the BRCA1 gene identified by a novel quantitative method. Cancer Res 2003; 63: 1449–1453.",
      "volume": "63",
      "year": "2003"
    },
    {
      "DOI": "10.1093/hmg/ddg120",
      "author": "M Montagna",
      "doi-asserted-by": "publisher",
      "first-page": "1055",
      "journal-title": "Hum Mol Genet",
      "key": "BFejhg201694_CR24",
      "unstructured": "Montagna M, Dalla PM, Menin C et al: Genomic rearrangements account for more than one-third of the BRCA1 mutations in northern Italian breast/ovarian cancer families. Hum Mol Genet 2003; 12: 1055–1061.",
      "volume": "12",
      "year": "2003"
    },
    {
      "DOI": "10.1093/hmg/10.7.705",
      "author": "PL Welcsh",
      "doi-asserted-by": "publisher",
      "first-page": "705",
      "journal-title": "Hum Mol Genet",
      "key": "BFejhg201694_CR25",
      "unstructured": "Welcsh PL, King MC : BRCA1 and BRCA2 and the genetics of breast and ovarian cancer. Hum Mol Genet 2001; 10: 705–713.",
      "volume": "10",
      "year": "2001"
    },
    {
      "DOI": "10.1007/s10549-011-1909-0",
      "author": "G Ruiz de Garibay",
      "doi-asserted-by": "publisher",
      "first-page": "273",
      "journal-title": "Breast Cancer Res Treat",
      "key": "BFejhg201694_CR26",
      "unstructured": "Ruiz de Garibay G, Gutierrez-Enriquez S, Garre P et al: Characterization of four novel BRCA2 large genomic rearrangements in Spanish breast/ovarian cancer families: review of the literature, and reevaluation of the genetic mechanisms involved in their origin. Breast Cancer Res Treat 2012; 133: 273–283.",
      "volume": "133",
      "year": "2012"
    },
    {
      "DOI": "10.1007/s10549-008-9978-4",
      "author": "A Peixoto",
      "doi-asserted-by": "publisher",
      "first-page": "31",
      "journal-title": "Breast Cancer Res Treat",
      "key": "BFejhg201694_CR27",
      "unstructured": "Peixoto A, Santos C, Rocha P et al: The c.156_157insAlu BRCA2 rearrangement accounts for more than one-fourth of deleterious BRCA mutations in northern/central Portugal. Breast Cancer Res Treat 2009; 114: 31–38.",
      "volume": "114",
      "year": "2009"
    },
    {
      "DOI": "10.1634/theoncologist.2012-0452",
      "author": "NM Lindor",
      "doi-asserted-by": "publisher",
      "first-page": "518",
      "journal-title": "Oncologist",
      "key": "BFejhg201694_CR28",
      "unstructured": "Lindor NM, Goldgar DE, Tavtigian SV et al: BRCA1/2 sequence variants of uncertain significance: a primer for providers to assist in discussions and in medical management. Oncologist 2013; 18: 518–524.",
      "volume": "18",
      "year": "2013"
    },
    {
      "DOI": "10.1200/JCO.2002.20.6.1480",
      "author": "TS Frank",
      "doi-asserted-by": "publisher",
      "first-page": "1480",
      "journal-title": "J Clin Oncol",
      "key": "BFejhg201694_CR29",
      "unstructured": "Frank TS, Deffenbaugh AM, Reid JE et al: Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals. J Clin Oncol 2002; 20: 1480–1490.",
      "volume": "20",
      "year": "2002"
    },
    {
      "DOI": "10.1136/jmg.2005.040212",
      "author": "F Casilli",
      "doi-asserted-by": "publisher",
      "first-page": "e49",
      "journal-title": "J Med Genet",
      "key": "BFejhg201694_CR30",
      "unstructured": "Casilli F, Tournier I, Sinilnikova OM et al: The contribution of germline rearrangements to the spectrum of BRCA2 mutations. J Med Genet 2006; 43: e49.",
      "volume": "43",
      "year": "2006"
    },
    {
      "DOI": "10.1038/jid.2013.248",
      "author": "A Grada",
      "doi-asserted-by": "publisher",
      "first-page": "e11",
      "journal-title": "J Invest Dermatol",
      "key": "BFejhg201694_CR31",
      "unstructured": "Grada A, Weinbrecht K : Next-generation sequencing: methodology and application. J Invest Dermatol 2013; 133: e11.",
      "volume": "133",
      "year": "2013"
    },
    {
      "DOI": "10.1586/erm.13.1",
      "author": "SF Idris",
      "doi-asserted-by": "publisher",
      "first-page": "167",
      "journal-title": "Expert Rev Mol Diagn",
      "key": "BFejhg201694_CR32",
      "unstructured": "Idris SF, Ahmad SS, Scott MA, Vassiliou GS, Hadfield J : The role of high-throughput technologies in clinical cancer genomics. Expert Rev Mol Diagn 2013; 13: 167–181.",
      "volume": "13",
      "year": "2013"
    },
    {
      "DOI": "10.1038/nbt.2198",
      "author": "NJ Loman",
      "doi-asserted-by": "publisher",
      "first-page": "434",
      "journal-title": "Nat Biotechnol",
      "key": "BFejhg201694_CR33",
      "unstructured": "Loman NJ, Misra RV, Dallman TJ et al: Performance comparison of benchtop high-throughput sequencing platforms. Nat Biotechnol 2012; 30: 434–439.",
      "volume": "30",
      "year": "2012"
    },
    {
      "DOI": "10.1146/annurev.genom.9.081307.164359",
      "author": "ER Mardis",
      "doi-asserted-by": "publisher",
      "first-page": "387",
      "journal-title": "Annu Rev Genomics Hum Genet",
      "key": "BFejhg201694_CR34",
      "unstructured": "Mardis ER : Next-generation DNA sequencing methods. Annu Rev Genomics Hum Genet 2008; 9: 387–402.",
      "volume": "9",
      "year": "2008"
    },
    {
      "DOI": "10.1073/pnas.1007983107",
      "author": "T Walsh",
      "doi-asserted-by": "publisher",
      "first-page": "12629",
      "journal-title": "Proc Natl Acad Sci USA",
      "key": "BFejhg201694_CR35",
      "unstructured": "Walsh T, Lee MK, Casadei S et al: Detection of inherited mutations for breast and ovarian cancer using genomic capture and massively parallel sequencing. Proc Natl Acad Sci USA 2010; 107: 12629–12633.",
      "volume": "107",
      "year": "2010"
    },
    {
      "DOI": "10.1002/humu.21216",
      "author": "JE Morgan",
      "doi-asserted-by": "publisher",
      "first-page": "484",
      "journal-title": "Hum Mutat",
      "key": "BFejhg201694_CR36",
      "unstructured": "Morgan JE, Carr IM, Sheridan E et al: Genetic diagnosis of familial breast cancer using clonal sequencing. Hum Mutat 2010; 31: 484–491.",
      "volume": "31",
      "year": "2010"
    },
    {
      "DOI": "10.1016/j.jmoldx.2012.06.003",
      "author": "M Chan",
      "doi-asserted-by": "publisher",
      "first-page": "602",
      "journal-title": "J Mol Diagn",
      "key": "BFejhg201694_CR37",
      "unstructured": "Chan M, Ji SM, Yeo ZX et al: Development of a next-generation sequencing method for BRCA mutation screening: a comparison between a high-throughput and a benchtop platform. J Mol Diagn 2012; 14: 602–612.",
      "volume": "14",
      "year": "2012"
    },
    {
      "DOI": "10.1002/humu.21428",
      "author": "K De Leeneer",
      "doi-asserted-by": "publisher",
      "first-page": "335",
      "journal-title": "Hum Mutat",
      "key": "BFejhg201694_CR38",
      "unstructured": "De Leeneer K, Hellemans J, De Schrijver J et al: Massive parallel amplicon sequencing of the breast cancer genes BRCA1 and BRCA2: opportunities, challenges, and limitations. Hum Mutat 2011; 32: 335–344.",
      "volume": "32",
      "year": "2011"
    },
    {
      "DOI": "10.1038/ejhg.2012.270",
      "author": "L Feliubadalo",
      "doi-asserted-by": "publisher",
      "first-page": "864",
      "journal-title": "Eur J Hum Genet",
      "key": "BFejhg201694_CR39",
      "unstructured": "Feliubadalo L, Lopez-Doriga A, Castellsague E et al: Next-generation sequencing meets genetic diagnostics: development of a comprehensive workflow for the analysis of BRCA1 and BRCA2 genes. Eur J Hum Genet 2013; 21: 864–870.",
      "volume": "21",
      "year": "2013"
    },
    {
      "DOI": "10.1038/ejhg.2013.181",
      "author": "J Tarabeux",
      "doi-asserted-by": "publisher",
      "first-page": "535",
      "journal-title": "Eur J Hum Genet",
      "key": "BFejhg201694_CR40",
      "unstructured": "Tarabeux J, Zeitouni B, Moncoutier V et al: Streamlined ion torrent PGM-based diagnostics: BRCA1 and BRCA2 genes as a model. Eur J Hum Genet 2014; 22: 535–541.",
      "volume": "22",
      "year": "2014"
    },
    {
      "DOI": "10.1038/ejhg.2014.16",
      "author": "L Castéra",
      "doi-asserted-by": "publisher",
      "first-page": "1305",
      "journal-title": "Eur J Hum Genet",
      "key": "BFejhg201694_CR41",
      "unstructured": "Castéra L, Krieger S, Rousselin A et al: Next-generation sequencing for the diagnosis of hereditary breast and ovarian cancer using genomic capture targeting multiple candidate genes. Eur J Hum Genet 2014; 22: 1305–1313.",
      "volume": "22",
      "year": "2014"
    },
    {
      "DOI": "10.1038/nrg2626",
      "author": "ML Metzker",
      "doi-asserted-by": "publisher",
      "first-page": "31",
      "journal-title": "Nat Rev Genet",
      "key": "BFejhg201694_CR42",
      "unstructured": "Metzker ML : Sequencing technologies - the next generation. Nat Rev Genet 2010; 11: 31–46.",
      "volume": "11",
      "year": "2010"
    },
    {
      "DOI": "10.1038/nature10242",
      "author": "JM Rothberg",
      "doi-asserted-by": "publisher",
      "first-page": "348",
      "journal-title": "Nature",
      "key": "BFejhg201694_CR43",
      "unstructured": "Rothberg JM, Hinz W, Rearick TM et al: An integrated semiconductor device enabling non-optical genome sequencing. Nature 2011; 475: 348–352.",
      "volume": "475",
      "year": "2011"
    },
    {
      "key": "BFejhg201694_CR44",
      "unstructured": "Glenn T 2014 NGS field guide: overview. The Molecular Ecologist 2014. Available at: http://www.molecularecologist.com/next-gen-fieldguide-2014/ ."
    },
    {
      "DOI": "10.1038/nmeth.1419",
      "author": "L Mamanova",
      "doi-asserted-by": "publisher",
      "first-page": "111",
      "journal-title": "Nat Methods",
      "key": "BFejhg201694_CR45",
      "unstructured": "Mamanova L, Coffey AJ, Scott CE et al: Target-enrichment strategies for next-generation sequencing. Nat Methods 2010; 7: 111–118.",
      "volume": "7",
      "year": "2010"
    },
    {
      "DOI": "10.1186/s13073-014-0121-3",
      "author": "JY Cheon",
      "doi-asserted-by": "publisher",
      "first-page": "121",
      "journal-title": "Genome Med",
      "key": "BFejhg201694_CR46",
      "unstructured": "Cheon JY, Mozersky J, Cook-Deegan R : Variants of uncertain significance in BRCA: a harbinger of ethical and policy issues to come? Genome Med 2014; 6: 121.",
      "volume": "6",
      "year": "2014"
    },
    {
      "DOI": "10.1016/j.jmoldx.2012.03.006",
      "author": "H Ozcelik",
      "doi-asserted-by": "publisher",
      "first-page": "467",
      "journal-title": "J Mol Diagn",
      "key": "BFejhg201694_CR47",
      "unstructured": "Ozcelik H, Shi X, Chang MC et al: Long-range PCR and next-generation sequencing of BRCA1 and BRCA2 in breast cancer. J Mol Diagn 2012; 14: 467–475.",
      "volume": "14",
      "year": "2012"
    },
    {
      "DOI": "10.1038/ng.128",
      "author": "PJ Campbell",
      "doi-asserted-by": "publisher",
      "first-page": "722",
      "journal-title": "Nat Genet",
      "key": "BFejhg201694_CR48",
      "unstructured": "Campbell PJ, Stephens PJ, Pleasance ED et al: Identification of somatically acquired rearrangements in cancer using genome-wide massively parallel paired-end sequencing. Nat Genet 2008; 40: 722–729.",
      "volume": "40",
      "year": "2008"
    },
    {
      "DOI": "10.1038/nmeth.1374",
      "author": "P Medvedev",
      "doi-asserted-by": "publisher",
      "first-page": "S13",
      "journal-title": "Nat Methods",
      "key": "BFejhg201694_CR49",
      "unstructured": "Medvedev P, Stanciu M, Brudno M : Computational methods for discovering structural variation with next-generation sequencing. Nat Methods 2009; 6: S13–S20.",
      "volume": "6",
      "year": "2009"
    },
    {
      "DOI": "10.1093/bioinformatics/bts146",
      "author": "J Li",
      "doi-asserted-by": "publisher",
      "first-page": "1307",
      "journal-title": "Bioinformatics",
      "key": "BFejhg201694_CR50",
      "unstructured": "Li J, Lupat R, Amarasinghe KC et al: CONTRA: copy number analysis for targeted resequencing. Bioinformatics 2012; 28: 1307–1313.",
      "volume": "28",
      "year": "2012"
    },
    {
      "DOI": "10.1186/1471-2164-12-184",
      "author": "AS Nord",
      "doi-asserted-by": "publisher",
      "first-page": "184",
      "journal-title": "BMC Genomics",
      "key": "BFejhg201694_CR51",
      "unstructured": "Nord AS, Lee M, King MC, Walsh T : Accurate and exact CNV identification from targeted high-throughput sequence data. BMC Genomics 2011; 12: 184.",
      "volume": "12",
      "year": "2011"
    },
    {
      "DOI": "10.1200/JCO.2009.27.2997",
      "author": "BT Hennessy",
      "doi-asserted-by": "publisher",
      "first-page": "3570",
      "journal-title": "J Clin Oncol",
      "key": "BFejhg201694_CR52",
      "unstructured": "Hennessy BT, Timms KM, Carey MS et al: Somatic mutations in BRCA1 and BRCA2 could expand the number of patients that benefit from poly (ADP ribose) polymerase inhibitors in ovarian cancer. J Clin Oncol 2010; 28: 3570–3576.",
      "volume": "28",
      "year": "2010"
    },
    {
      "DOI": "10.1016/S1470-2045(13)70240-7",
      "author": "SK Sandhu",
      "doi-asserted-by": "publisher",
      "first-page": "882",
      "journal-title": "Lancet Oncol",
      "key": "BFejhg201694_CR53",
      "unstructured": "Sandhu SK, Schelman WR, Wilding G et al: The poly(ADP-ribose) polymerase inhibitor niraparib (MK4827) in BRCA mutation carriers and patients with sporadic cancer: a phase 1 dose-escalation trial. Lancet Oncol 2013; 14: 882–892.",
      "volume": "14",
      "year": "2013"
    },
    {
      "DOI": "10.1016/S1470-2045(14)70228-1",
      "author": "J Ledermann",
      "doi-asserted-by": "publisher",
      "first-page": "852",
      "journal-title": "Lancet Oncol",
      "key": "BFejhg201694_CR54",
      "unstructured": "Ledermann J, Harter P, Gourley C et al: Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: a preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trial. Lancet Oncol 2014; 15: 852–861.",
      "volume": "15",
      "year": "2014"
    },
    {
      "author": "JM Lee",
      "first-page": "dju089",
      "journal-title": "J Natl Cancer Inst",
      "key": "BFejhg201694_CR55",
      "unstructured": "Lee JM, Hays JL, Annunziata CM et al: Phase I/Ib study of olaparib and carboplatin in BRCA1 or BRCA2 mutation-associated breast or ovarian cancer with biomarker analyses. J Natl Cancer Inst 2014; 106: dju089.",
      "volume": "106",
      "year": "2014"
    },
    {
      "DOI": "10.1093/annonc/mdu187",
      "author": "J Balmana",
      "doi-asserted-by": "publisher",
      "first-page": "1656",
      "journal-title": "Ann Oncol",
      "key": "BFejhg201694_CR56",
      "unstructured": "Balmana J, Tung NM, Isakoff SJ et al: Phase I trial of olaparib in combination with cisplatin for the treatment of patients with advanced breast, ovarian and other solid tumors. Ann Oncol 2014; 25: 1656–1663.",
      "volume": "25",
      "year": "2014"
    },
    {
      "DOI": "10.1373/clinchem.2012.202390",
      "author": "H Do",
      "doi-asserted-by": "publisher",
      "first-page": "1376",
      "journal-title": "Clin Chem",
      "key": "BFejhg201694_CR57",
      "unstructured": "Do H, Wong SQ, Li J, Dobrovic A : Reducing sequence artifacts in amplicon-based massively parallel sequencing of formalin-fixed paraffin-embedded DNA by enzymatic depletion of uracil-containing templates. Clin Chem 2013; 59: 1376–1383.",
      "volume": "59",
      "year": "2013"
    },
    {
      "DOI": "10.18632/oncotarget.503",
      "author": "H Do",
      "doi-asserted-by": "publisher",
      "first-page": "546",
      "journal-title": "Oncotarget",
      "key": "BFejhg201694_CR58",
      "unstructured": "Do H, Dobrovic A : Dramatic reduction of sequence artefacts from DNA isolated from formalin-fixed cancer biopsies by treatment with uracil- DNA glycosylase. Oncotarget 2012; 3: 546–558.",
      "volume": "3",
      "year": "2012"
    },
    {
      "DOI": "10.1186/1755-8794-7-23",
      "author": "SQ Wong",
      "doi-asserted-by": "publisher",
      "first-page": "23",
      "journal-title": "BMC Med Genomics",
      "key": "BFejhg201694_CR59",
      "unstructured": "Wong SQ, Li J, Tan AY et al: Sequence artefacts in a prospective series of formalin-fixed tumours tested for mutations in hotspot regions by massively parallel sequencing. BMC Med Genomics 2014; 7: 23.",
      "volume": "7",
      "year": "2014"
    },
    {
      "DOI": "10.1371/journal.pone.0005548",
      "author": "MR Schweiger",
      "doi-asserted-by": "publisher",
      "first-page": "e5548",
      "journal-title": "PLoS One",
      "key": "BFejhg201694_CR60",
      "unstructured": "Schweiger MR, Kerick M, Timmermann B et al: Genome-wide massively parallel sequencing of formaldehyde fixed-paraffin embedded (FFPE) tumor tissues for copy-number- and mutation-analysis. PLoS One 2009; 4: e5548.",
      "volume": "4",
      "year": "2009"
    },
    {
      "DOI": "10.1186/1755-8794-4-68",
      "author": "M Kerick",
      "doi-asserted-by": "publisher",
      "first-page": "68",
      "journal-title": "BMC Med Genomics",
      "key": "BFejhg201694_CR61",
      "unstructured": "Kerick M, Isau M, Timmermann B et al: Targeted high throughput sequencing in clinical cancer settings: formaldehyde fixed-paraffin embedded (FFPE) tumor tissues, input amount and tumor heterogeneity. BMC Med Genomics 2011; 4: 68.",
      "volume": "4",
      "year": "2011"
    },
    {
      "DOI": "10.1186/s12907-015-0004-6",
      "author": "G Ellison",
      "doi-asserted-by": "publisher",
      "first-page": "5",
      "journal-title": "BMC Clin Pathol",
      "key": "BFejhg201694_CR62",
      "unstructured": "Ellison G, Huang S, Carr H et al: A reliable method for the detection of BRCA1 and BRCA2 mutations in fixed tumour tissue utilising multiplex PCR-based targeted next generation sequencing. BMC Clin Pathol 2015; 15: 5.",
      "volume": "15",
      "year": "2015"
    },
    {
      "DOI": "10.1111/j.1524-4741.2010.01055.x",
      "author": "K Ready",
      "doi-asserted-by": "publisher",
      "first-page": "210",
      "journal-title": "Breast J",
      "key": "BFejhg201694_CR63",
      "unstructured": "Ready K, Gutierrez-Barrera AM, Amos C et al: Cancer risk management decisions of women with BRCA1 or BRCA2 variants of uncertain significance. Breast J 2011; 17: 210–212.",
      "volume": "17",
      "year": "2011"
    },
    {
      "DOI": "10.1002/humu.21628",
      "author": "AB Spurdle",
      "doi-asserted-by": "publisher",
      "first-page": "2",
      "journal-title": "Hum Mutat",
      "key": "BFejhg201694_CR64",
      "unstructured": "Spurdle AB, Healey S, Devereau A et al: ENIGMA—evidence-based network for the interpretation of germline mutant alleles: an international initiative to evaluate risk and clinical significance associated with sequence variation in BRCA1 and BRCA2 genes. Hum Mutat 2012; 33: 2–7.",
      "volume": "33",
      "year": "2012"
    },
    {
      "DOI": "10.1002/1098-1004(200008)16:2\u003c123::AID-HUMU4\u003e3.0.CO;2-Y",
      "author": "C Szabo",
      "doi-asserted-by": "publisher",
      "first-page": "123",
      "journal-title": "Hum Mutat",
      "key": "BFejhg201694_CR65",
      "unstructured": "Szabo C, Masiello A, Ryan JF, Brody LC : The breast cancer information core: database design, structure, and scope. Hum Mutat 2000; 16: 123–131.",
      "volume": "16",
      "year": "2000"
    },
    {
      "DOI": "10.1002/humu.21629",
      "author": "MP Vallee",
      "doi-asserted-by": "publisher",
      "first-page": "22",
      "journal-title": "Hum Mutat",
      "key": "BFejhg201694_CR66",
      "unstructured": "Vallee MP, Francy TC, Judkins MK et al: Classification of missense substitutions in the BRCA genes: a database dedicated to Ex-UVs. Hum Mutat 2012; 33: 22–28.",
      "volume": "33",
      "year": "2012"
    },
    {
      "key": "BFejhg201694_CR67",
      "unstructured": "BRCA Challenge. The Human Variome Project. Available at: http://www.humanvariomeproject.org/brca-challenge.html . (accessed on 06 November 2014)."
    },
    {
      "DOI": "10.1038/ng.2854",
      "author": "BA Thompson",
      "doi-asserted-by": "publisher",
      "first-page": "107",
      "journal-title": "Nat Genet",
      "key": "BFejhg201694_CR68",
      "unstructured": "Thompson BA, Spurdle AB, Plazzer JP et al: Application of a 5-tiered scheme for standardized classification of 2,360 unique mismatch repair gene variants in the InSiGHT locus-specific database. Nat Genet 2014; 46: 107–115.",
      "volume": "46",
      "year": "2014"
    },
    {
      "DOI": "10.1038/gim.2014.185",
      "author": "CL Scherr",
      "doi-asserted-by": "publisher",
      "first-page": "739",
      "journal-title": "Genet Med",
      "key": "BFejhg201694_CR69",
      "unstructured": "Scherr CL, Lindor NM, Malo TL, Couch FJ, Vadaparampil ST : A preliminary investigation of genetic counselors' information needs when receiving a variant of uncertain significance result: a mixed methods study. Genet Med 2015; 17: 739–746.",
      "volume": "17",
      "year": "2015"
    },
    {
      "DOI": "10.1089/10906570260199357",
      "author": "N Petrucelli",
      "doi-asserted-by": "publisher",
      "first-page": "107",
      "journal-title": "Genet Test",
      "key": "BFejhg201694_CR70",
      "unstructured": "Petrucelli N, Lazebnik N, Huelsman KM, Lazebnik RS : Clinical interpretation and recommendations for patients with a variant of uncertain significance in BRCA1 or BRCA2: a survey of genetic counseling practice. Genet Test 2002; 6: 107–113.",
      "volume": "6",
      "year": "2002"
    },
    {
      "DOI": "10.1002/humu.20880",
      "author": "SE Plon",
      "doi-asserted-by": "publisher",
      "first-page": "1282",
      "journal-title": "Hum Mutat",
      "key": "BFejhg201694_CR71",
      "unstructured": "Plon SE, Eccles DM, Easton D et al: Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results. Hum Mutat 2008; 29: 1282–1291.",
      "volume": "29",
      "year": "2008"
    },
    {
      "DOI": "10.1097/GIM.0b013e31816b5cae",
      "author": "CS Richards",
      "doi-asserted-by": "publisher",
      "first-page": "294",
      "journal-title": "Genet Med",
      "key": "BFejhg201694_CR72",
      "unstructured": "Richards CS, Bale S, Bellissimo DB et al: ACMG recommendations for standards for interpretation and reporting of sequence variations: revisions 2007. Genet Med 2008; 10: 294–300.",
      "volume": "10",
      "year": "2008"
    }
  ],
  "reference-count": 72,
  "references-count": 72,
  "resource": {
    "primary": {
      "URL": "https://www.nature.com/articles/ejhg201694"
    }
  },
  "score": 0,
  "short-container-title": [
    "Eur J Hum Genet"
  ],
  "source": "Crossref",
  "title": [
    "New challenges for BRCA testing: a view from the diagnostic laboratory"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "24"
}